Clinical Trials


ROA doctors are committed to enrolling patients on clinical trials whenever possible.  Clinical trials can bring cutting edge therapies to our patients, and will help define better treatments for future generations.

Below are listed clinical trials that are available at our Ascension sites (For the Aurora trials page click here).  Efforts are made to keep this list up to date, but please understand that trials are frequently opening and closing, and not all trials are available at all sites.  Your ROA doctor will know what is available for your cancer and can answer any questions.

The information below is mainly from, a large public database of clinical trials.  Click on the links for more information.

Bladder Cancer 

SWOG S1806  Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer 

This phase III trial studies how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer.   


Prostate Cancer 

A222001 Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer 

This phase II trial compares the effect of oxybutynin versus placebo for reducing hot flashes in men receiving androgen deprivation (hormone) therapy for the treatment of prostate cancer .  


Head and Neck (throat, tonsil, larynx, etc) Cancer 

NRG HN005  De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer 

This phase II/III trial studies how well a reduced dose of radiation therapy works with nivolumab compared to cisplatin in treating patients with human papillomavirus (HPV)-positive oropharyngeal cancer that is early in its growth and may not have spread to other parts of the body (early-stage), and is not associated with smoking.   


Lung Cancer 

SWOG S1914  Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer 

This phase III trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. 


S1933 Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients 

This trial studies the side effects of radiation therapy followed by atezolizumab in treating patients with stage II or III non-small cell lung cancer.  

Radiation Oncology Associates